Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Rheumatology board review / / editor, Karen Law ; associate editor, Aliza Lipson ; cover design by Matt Kuhns
| Rheumatology board review / / editor, Karen Law ; associate editor, Aliza Lipson ; cover design by Matt Kuhns |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (ix, 214 pages) : illustrations (some color) |
| Disciplina | 616.723 |
| Altri autori (Persone) |
LawKaren
LipsonAliza KuhnsMatt |
| Soggetto topico |
Rheumatism
Rheumatology |
| ISBN |
1-118-47597-6
1-118-47594-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title page; Copyright page; Contents; List of Contributors; Preface; CHAPTER 1: Non-inflammatory joint and soft tissue disorders; Introduction; Carpal tunnel syndrome; Epidemiology; Pathology; Clinical presentation; Diagnosis; Treatment; Differential diagnosis; Osteoarthritis (OA); Epidemiology; Commonly involved joints; Definition; Risk factors; Pathogenesis; Symptoms; Physical examination; Osteoarthritis treatment; Secondary osteoarthritis; Etiologies; Inflammatory/erosive hand osteoarthritis; Diagnosis; Clinical features; Radiological features; Differential diagnosis for IE-HOA
TreatmentDiffuse idiopathic skeletal hyperostosis (DISH); Introduction; Clinical findings; Radiologic findings (see also Chapter 11, Review of musculoskeletal radiology); Diagnosis; Differential diagnosis; Treatment; Gout; Causes of early-onset gout; Drugs causing hyperuricemia; Gout treatments; Further reading; CHAPTER 2: Selected topics in rheumatoid arthritis; Introduction; 2010 ACR/EULAR RA classification criteria; Anti-citrullinated antibodies; What are they?; What is the role of ACPA in the diagnosis of RA?; Rheumatoid arthritis and cardiovascular disease Treatment advances in rheumatoid arthritisAnakinra - approved 2001; Abatacept - approved 2006; Rituximab - approved 2006; Tocilizumab - approved 2010; Appropriate immunizations and screening in RA patients; Tuberculosis screening; Key points in using vaccines in RA patients; Drug toxicity monitoring; CHAPTER 3: Selected topics in systemic lupus erythematosus: B cells in lupus and lupus nephritis; Introduction; B cell roles in SLE; Therapies targeting B cells; Specific approaches; Existing therapies for SLE; Rituximab; Belimumab Additional therapies targeting B cells in SLE under investigationLupus nephritis; Classification criteria; American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis; CHAPTER 4: Antiphospholipid antibody syndrome; Introduction; Epidemiology; Classification criteria; Clinical criteria; Laboratory criteria; Important considerations stated by the revised Sapporo classification criteria for the APS; The clinical spectrum of APS; aPL antibodies laboratory testing; Lupus anticoagulants (LACs); aCL antibodies and anti-β2GPI antibodies Limitations of aPL testingWho should be tested?; Who should not be tested?; Testing individuals on anticoagulant therapy; Treatment; Primary and secondary prevention of thrombosis in individuals with aPL; Management of pregnancy outcomes in women with aPL; CHAPTER 5: IgG4-related disease; Introduction; Histology; Epidemiology; Etiology; Clinical manifestations; Differential diagnosis; Specific organ involvement in IgG4-RD; Head and neck area; Thoracic area; Abdomen and pelvic area; Diagnostic studies; Value of serum IgG4 in the diagnosis of IgG4-RD; Treatment; Prognosis; CHAPTER 6: Myopathies Introduction |
| Record Nr. | UNINA-9910138988803321 |
| Hoboken, New Jersey : , : Wiley Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rheumatology board review / / editor, Karen Law ; associate editor, Aliza Lipson ; cover design by Matt Kuhns
| Rheumatology board review / / editor, Karen Law ; associate editor, Aliza Lipson ; cover design by Matt Kuhns |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (ix, 214 pages) : illustrations (some color) |
| Disciplina | 616.723 |
| Altri autori (Persone) |
LawKaren
LipsonAliza KuhnsMatt |
| Soggetto topico |
Rheumatism
Rheumatology |
| ISBN |
1-118-47597-6
1-118-47594-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title page; Copyright page; Contents; List of Contributors; Preface; CHAPTER 1: Non-inflammatory joint and soft tissue disorders; Introduction; Carpal tunnel syndrome; Epidemiology; Pathology; Clinical presentation; Diagnosis; Treatment; Differential diagnosis; Osteoarthritis (OA); Epidemiology; Commonly involved joints; Definition; Risk factors; Pathogenesis; Symptoms; Physical examination; Osteoarthritis treatment; Secondary osteoarthritis; Etiologies; Inflammatory/erosive hand osteoarthritis; Diagnosis; Clinical features; Radiological features; Differential diagnosis for IE-HOA
TreatmentDiffuse idiopathic skeletal hyperostosis (DISH); Introduction; Clinical findings; Radiologic findings (see also Chapter 11, Review of musculoskeletal radiology); Diagnosis; Differential diagnosis; Treatment; Gout; Causes of early-onset gout; Drugs causing hyperuricemia; Gout treatments; Further reading; CHAPTER 2: Selected topics in rheumatoid arthritis; Introduction; 2010 ACR/EULAR RA classification criteria; Anti-citrullinated antibodies; What are they?; What is the role of ACPA in the diagnosis of RA?; Rheumatoid arthritis and cardiovascular disease Treatment advances in rheumatoid arthritisAnakinra - approved 2001; Abatacept - approved 2006; Rituximab - approved 2006; Tocilizumab - approved 2010; Appropriate immunizations and screening in RA patients; Tuberculosis screening; Key points in using vaccines in RA patients; Drug toxicity monitoring; CHAPTER 3: Selected topics in systemic lupus erythematosus: B cells in lupus and lupus nephritis; Introduction; B cell roles in SLE; Therapies targeting B cells; Specific approaches; Existing therapies for SLE; Rituximab; Belimumab Additional therapies targeting B cells in SLE under investigationLupus nephritis; Classification criteria; American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis; CHAPTER 4: Antiphospholipid antibody syndrome; Introduction; Epidemiology; Classification criteria; Clinical criteria; Laboratory criteria; Important considerations stated by the revised Sapporo classification criteria for the APS; The clinical spectrum of APS; aPL antibodies laboratory testing; Lupus anticoagulants (LACs); aCL antibodies and anti-β2GPI antibodies Limitations of aPL testingWho should be tested?; Who should not be tested?; Testing individuals on anticoagulant therapy; Treatment; Primary and secondary prevention of thrombosis in individuals with aPL; Management of pregnancy outcomes in women with aPL; CHAPTER 5: IgG4-related disease; Introduction; Histology; Epidemiology; Etiology; Clinical manifestations; Differential diagnosis; Specific organ involvement in IgG4-RD; Head and neck area; Thoracic area; Abdomen and pelvic area; Diagnostic studies; Value of serum IgG4 in the diagnosis of IgG4-RD; Treatment; Prognosis; CHAPTER 6: Myopathies Introduction |
| Record Nr. | UNINA-9910807753103321 |
| Hoboken, New Jersey : , : Wiley Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autore (Persona)
- KuhnsMatt (2)
-
LawKaren
(2)
- LipsonAliza (2)
Soggetto topico
-
Rheumatism
(2)
- Rheumatology (2)